Outsmarting Metastatic Prostate Cancer: Integration of Imaging, Liquid Biopsies and Biomarkers With Artificial Intelligence - PubMed
7 hours ago
- #Precision Oncology
- #Artificial Intelligence
- #Metastatic Prostate Cancer
- The review focuses on integrating artificial intelligence (AI) with imaging, liquid biopsies, and biomarkers to manage metastatic prostate cancer (mPCa).
- AI enhances diagnostic accuracy, risk stratification, and personalized treatment guidance for mPCa by analyzing complex datasets.
- Key challenges and opportunities in deploying AI systems include multimodal integration and validation for real-world clinical impact.